Bank manager: A change towards foreign venture capital, however…
In recent years Henrik Specht, business account manager in Danske Bank, has noticed a shift towards foreign venture capital in the biotech industry, but the Danes could yet be making a comeback.
by Stefan Singh Kailay
There is widespread consensus in the biotech industry that capital is extremely hard to come by these days. An issue that business account manager Henrik Specht is also faced with, when he sits down with the biotech companies, whose bank accounts he manages.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
